180 likes | 377 Views
Asia Consortium Regional chapter in Asia. ISPOR- INDIA Chapter Jawahar Bapna PhD, MD, MBBS Adjunct Professor, Pharmaceutical Management Institute of Health Management Research Jaipur. India Chapter - Historical. Dr. JS Bapna attended ISPOR meeting at Washinton DC in 1998
E N D
Asia Consortium Regional chapter in Asia ISPOR-INDIA Chapter Jawahar Bapna PhD, MD, MBBS Adjunct Professor, Pharmaceutical Management Institute of Health Management Research Jaipur
India Chapter - Historical • Dr. JS Bapna attended ISPOR meeting at Washinton DC in 1998 • Organized Pharmacoeconomic courses sponsored by WHO held in 2002 at Delhi/Jaipur • India Chapter Inception - May, 2006 • Initially 30 Members. • Now 120 Members • Inaugural meeting at Delhi • Executive committee elected
Current leadership of the India Chapter • President:Harish Narula, Chairman, Bharat Shakti, Spiritual, Cultural & Educational Society (NGO),New Delhi, Vice President:Shashidhar Rao, MBA, MD, MBBS Head, Medical Research Specialists, Medical and Research Medical and Research Division, Novartis Ltd., Hyderabad Vice President:Suresh K. Gupta, PhD, MSc Director General & Dean Institute of Clinical Research India New Delhi • Secretary: Jawahar S. Bapna PhD, MD, MBBS Adjunct Professor, Pharmaceutical Management Institute of Health Management Research Jaipur
Participation of Members in ISPOR Meetings Aborad • Dr. Jawahar Bapna, Dr ShashiDhar Rao, China • Dr Anita Kotwani, USA • Dr.Sangeeta Sharma, Canada • Dr. Urmila Thate at Korea • Dr Anita Kotwani, USA, Thailand 2010 • Dr ShashiDhar Rao, Thailand 2010
Activities of 2010 ISPOR–India Annual meeting Symposium on Outcomes Research along with Pradanya at IIHMR, Jaipur, Nov 26, 2010 • Health Economics and the Pharmaceutical Industry: The Fourth Hurdle Rosemary Jose, PhD, Novartis • Patient-reported Outcome: An overview Rumjhum Agrawal, Novartis
Activities of 2010 ISPOR–India Annual meeting Symposium on Outcomes Research along with Pradanya at Hotel Mansingh, Jaipur, Nov 27, 2010 • Introduction to Outcomes Research and Health Economics, The Why? What? Of Outcomes Research and Pharmacoeconomic Analyses. Policies in India and West. Dr Shalini Menon, Senior Medical Advisor, & Clinical Development Lead, Pfizer Ltd. • Methods for economic assessment : examples Impact on health care Application of Outcomes Research in Managed Health Care/Health Insurance settings and the Growing Need in India Dr Salil Shinde, Senior Medical Advisor, Pfizer Ltd.
Activities of 2011 • Feb 27 to March 10: International Training Course on Promoting Rational Drug Use in the Community • Venue: Institute of Health Management Research, Jaipur • Ccoordinator: Jawahar S Bapna • WHO Expert: Dr. Gitanjali Batmanabane • 40 Participant from 14 countries participated • Outcome: Participants prepared research projects on Rational Use of Drugs to be conducted in their own settings • June 3 ISPOR National Conference, at New Delhi • Venue: India International Centre, New Delhi • The 3rd June meeting, in lieu of World Environment Day (5th June, 2011), Mr. Harish Narula, Chairman of Bharat Shakti Spiritual , Cultural & Educational Society has initiated to organize a Seminar to create awareness in Environment and also in Drug Use and abuse.
Activities planned for 2011 • December - Joint PEOR National meeting with IIHMR in mid December 2011 • ‘Theme: Pharmacoeconomics and Pharmacovigilance’ • Explore the possibility of some resource/representative form ISPOR, USA at the National Meeting.
Future Plans • Pharmacovigilance • Ethics in clinical trials • Liaison with drugs control organization • Pharmacoeconomics and Outcomes Research activities to be initiated
Future Plans • Invitation to ISPOR Asia-Pacific Conference in India 2016
Challenges • Need to have a office in Delhi for its registration • Need to register it at Delhi • Make more members of it • Have Elections of Executive of the chapter in 2011
Publications • Tarn YH, Hu S, Kamae I, Yang BM, Li SC, Tangcharoensathien V, Teerawattananon Y, Limwattananon S, Hameed A, Aljunid SM, Bapna JS. Health-care systems and pharmacoeconomic research in Asia-Pacific region. Value Health. 2008 Mar;11 Suppl 1:S137-55. • Chaudhury RR, Parameswar R, Gupta U, Sharma S, Tekur U, Bapna JS. Quality medicines for the poor: experience of the Delhi programme on rational use of drugs. Health Policy Plan. 2005 Mar; 20(2): 124-36. • Singh,Jatinder.‘ Web-wise’ on International Society for Pharmacoeconomics and Outcomes Research. Indian J Pharmacol. 38: 376-77, 2006